Well Health - Digitale Services für die Medizin
eröffnet am 12.11.22 11:39:23 von
neuester Beitrag 16.04.24 19:41:09 von
neuester Beitrag 16.04.24 19:41:09 von
Beiträge: 93
ID: 1.364.777
ID: 1.364.777
Aufrufe heute: 19
Gesamt: 7.802
Gesamt: 7.802
Aktive User: 0
ISIN: CA94947L1022 · WKN: A2JQV6 · Symbol: W7V
2,4060
EUR
0,00 %
0,0000 EUR
Letzter Kurs 18.04.24 Tradegate
Meistbewertete Beiträge
| Datum | Beiträge | Bewertungen |
|---|---|---|
| 13.04.24 |
| Datum | Beiträge | Bewertungen |
|---|---|---|
| 13.04.24 |
Werte aus der Branche Finanzdienstleistungen
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 3,0000 | +500,00 | |
| 1,2900 | +36,33 | |
| 1,3750 | +34,80 | |
| 1,1100 | +21,31 | |
| 0,6000 | +20,00 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 5,0800 | -11,83 | |
| 10,574 | -14,05 | |
| 9,8500 | -17,92 | |
| 1,5000 | -23,08 | |
| 0,7500 | -25,00 |
Beitrag zu dieser Diskussion schreiben
Feedback
Heute super Zahlenwerk von UnitedHealth das könnte hier auch helfen, denke ich!!!!
Was hier noch keiner auf dem Schirm hat, ist das Well noch 90% der Anteile von Well AI hält. Diese werden gerade mit 100.000.000 bewertet. Da schlummert ein Vermögen 😀
Hier findet sich wohl der Grund für die schwache Performance. US-Krankenversicherer erwischten am Dienstag einen ganz schwachen Handelstag. Grund für die ungewöhnlich heftigen Kursverluste bei UnitedHealth und Humana war die jüngste Entscheidung der US-Gesundheitsbehörde CMS.
Oder die Zahlen waren nicht so gut wie erwartet. In Wahljahren läuft der Gesundheitssektor in den USA meist nicht gut, vllt auch ein Grund. Für mich jedenfalls kein Grund auszusteigen, ich habe bei 2,60 EUR nachgelegt.
WELL Health keeps $8.50 target at PI
Following the company’s fourth quarter results, PI Financial analyst Jason Zandberg has maintained his bullish price target on WELL Health (WELL Health Stock Quote, Chart, News, Analysts, Financials TSX:WELL).
On March 21, WELL reported its Q4 and fiscal 2023 results. In the fourth quarter, the company posted Adjusted EBITDA of $30.8-million on revenue of $231.2-million, a topline that was up 48 per cent over the same period a year prior.
“We had an outstanding year in 2023 with record revenue, adjusted EBITDA [earnings before interest, taxes, depreciation and amortization], net income and patient visits,” CEO Hamed Shahbazi said. “I am proud to announce that with the inclusion of growth associated with our clinic absorption program where Well is attracting clinics to its network for nominal consideration, we achieved organic growth of 15 per cent and overall revenue growth of 36 per cent in 2023 driven by strong operating results across all our business units.
...
In a research update to clients March 22, Zandberg maintained his “Buy” rating and $8.50 target on WELL, implying a return of 123.1% at the time of publication.
The analyst described the results as “mostly positive”, noting the minor dip in EBITDA was offset by revenue increases.
...
Zandberg thinks WELL will post Adjusted EBITDA of $124.9-million on revenue of $955.0-million in fiscal 2024. He expects those numbers will improve to Adjusted EBITDA of $150.0-million on a topline of $1.06-billion the following year.
...
https://www.cantechletter.com/2024/03/well-health-keeps-8-50…
WELL Health keeps $8.50 target at PI
Following the company’s fourth quarter results, PI Financial analyst Jason Zandberg has maintained his bullish price target on WELL Health (WELL Health Stock Quote, Chart, News, Analysts, Financials TSX:WELL).
On March 21, WELL reported its Q4 and fiscal 2023 results. In the fourth quarter, the company posted Adjusted EBITDA of $30.8-million on revenue of $231.2-million, a topline that was up 48 per cent over the same period a year prior.
“We had an outstanding year in 2023 with record revenue, adjusted EBITDA [earnings before interest, taxes, depreciation and amortization], net income and patient visits,” CEO Hamed Shahbazi said. “I am proud to announce that with the inclusion of growth associated with our clinic absorption program where Well is attracting clinics to its network for nominal consideration, we achieved organic growth of 15 per cent and overall revenue growth of 36 per cent in 2023 driven by strong operating results across all our business units.
...
In a research update to clients March 22, Zandberg maintained his “Buy” rating and $8.50 target on WELL, implying a return of 123.1% at the time of publication.
The analyst described the results as “mostly positive”, noting the minor dip in EBITDA was offset by revenue increases.
...
Zandberg thinks WELL will post Adjusted EBITDA of $124.9-million on revenue of $955.0-million in fiscal 2024. He expects those numbers will improve to Adjusted EBITDA of $150.0-million on a topline of $1.06-billion the following year.
...
https://www.cantechletter.com/2024/03/well-health-keeps-8-50…
hm, also war das sell on good news!?!!! ok sehe das ähnlich wie der Verfasser des Artikels. Habe mich nur über die Heftigkeit gewundert oder so nicht erwartet.
Trading Spotlight
Here Are 3 Phenomenal Reasons to Buy Well Health Stock Right Now
Well Health stock has been hit hard in the last three years, yet fundamentals remain strong and keep hitting records.
Well Health Technologies (TSX:WELL) has had an interesting couple of years. The company continues to post record results, yet Well Health’s stock price continues to decline. It’s a dichotomy that I don’t think will last too long. Therefore, I would consider acting now.
Here are three reasons to buy Well Health Stock right now.
Well Health stock continues to get crushed
For shareholders like me, watching Well Health’s stock price tumble has not been fun. Yet, for all the frustration it is causing me, it’s also giving me the opportunity to buy more of the stock at lower prices. If I believe in the long-term story, this is exactly what I should be doing.
As you can see from the graph below, Well Health Technologies stock has declined 20%. In the last three years, it has declined 52%. The problem with the stock, in my view, is that it is what we can classify as a high-risk stock. In this market, high-risk stocks have not generally been the best performers due to the lower risk tolerance of investors relative to a few years ago.
In addition to this, the fact that the company has been operating with net losses and will increase debt due to its acquisition strategy makes it easy to see why investors are risk averse. But the company continues to post record revenues and is now finally turning the corner to profitability.
Well Health’s results reflect strong demand
In 2018, Well Health reported revenue of $10.6 million. In 2023, revenue totalled $776.1 million, 36% higher than last year. This is a dramatic increase and a reflection of the need that the company is addressing. It is, in fact, revolutionizing health care systems. This is driving efficiencies, better patient care, and, ultimately, a better experience for both providers and patients.
Looking ahead, Well Health management has increased its revenue guidance once again. For 2024, we can expect revenue to come in between $950 million and $970 million for an up to 25% growth rate.
Along with this revenue growth, Well Health has been driving profitability. On this front, the company is making good progress. 2024 estimates are calling for a break-even year, which compares to net losses in many prior years. Sustained profitability will come in 2025, with expectations calling for earnings per share of $0.09.
The digitization of health care has only just begun
The healthcare system has been notoriously behind in its use of technology despite the many advantages that it brings. Well Health saw the opportunity and began its digitization quest. And this quest has only just begun.
...
https://www.fool.ca/2024/03/22/here-are-3-phenomenal-reasons…
Well Health stock has been hit hard in the last three years, yet fundamentals remain strong and keep hitting records.
Well Health Technologies (TSX:WELL) has had an interesting couple of years. The company continues to post record results, yet Well Health’s stock price continues to decline. It’s a dichotomy that I don’t think will last too long. Therefore, I would consider acting now.
Here are three reasons to buy Well Health Stock right now.
Well Health stock continues to get crushed
For shareholders like me, watching Well Health’s stock price tumble has not been fun. Yet, for all the frustration it is causing me, it’s also giving me the opportunity to buy more of the stock at lower prices. If I believe in the long-term story, this is exactly what I should be doing.
As you can see from the graph below, Well Health Technologies stock has declined 20%. In the last three years, it has declined 52%. The problem with the stock, in my view, is that it is what we can classify as a high-risk stock. In this market, high-risk stocks have not generally been the best performers due to the lower risk tolerance of investors relative to a few years ago.
In addition to this, the fact that the company has been operating with net losses and will increase debt due to its acquisition strategy makes it easy to see why investors are risk averse. But the company continues to post record revenues and is now finally turning the corner to profitability.
Well Health’s results reflect strong demand
In 2018, Well Health reported revenue of $10.6 million. In 2023, revenue totalled $776.1 million, 36% higher than last year. This is a dramatic increase and a reflection of the need that the company is addressing. It is, in fact, revolutionizing health care systems. This is driving efficiencies, better patient care, and, ultimately, a better experience for both providers and patients.
Looking ahead, Well Health management has increased its revenue guidance once again. For 2024, we can expect revenue to come in between $950 million and $970 million for an up to 25% growth rate.
Along with this revenue growth, Well Health has been driving profitability. On this front, the company is making good progress. 2024 estimates are calling for a break-even year, which compares to net losses in many prior years. Sustained profitability will come in 2025, with expectations calling for earnings per share of $0.09.
The digitization of health care has only just begun
The healthcare system has been notoriously behind in its use of technology despite the many advantages that it brings. Well Health saw the opportunity and began its digitization quest. And this quest has only just begun.
...
https://www.fool.ca/2024/03/22/here-are-3-phenomenal-reasons…
Ist mir etwas durchgegangen? Warum gehts jetzt so abwärts???
Geschafft!!! 
Danke an Winston-wolfe
Danke an Winston-wolfe
@Winston-wolfe ja da hast du vollkommen Recht. Es ist ein Start up aber das macht es doch so interessant. Jetzt mit dem Neuen CEO dem Ex vom Mutterkonzern . Da spricht doch einiges für einen guten Verlauf. Könntest du mir einen Chat bei Well AI aufmachen, ich bekomme das irgendwie nicht hin. Habe die Nachrichten von Beiden Unternehmen bekommen und gelesen. Danke für die Info
Antwort auf Beitrag Nr.: 75.494.775 von Chash-Carry am 21.03.24 14:43:09Nein, Healwell ist mir zu Start-up, hat noch wenig Umsatz und macht keinen Gewinn. Lass die mal noch ein-zwei Jahre auf die Weide.
Ich hoffe Healwell wird ein weiteres erfolgreiches Puzzlestück in der Gesamtstory Well Health.
Healwell hat übrigens auch berichtet https://www.finanznachrichten.de/nachrichten-2024-03/6174544…
Ich hoffe Healwell wird ein weiteres erfolgreiches Puzzlestück in der Gesamtstory Well Health.
Healwell hat übrigens auch berichtet https://www.finanznachrichten.de/nachrichten-2024-03/6174544…
Zitat von Chash-Carry: Ja hab ich gesehen und gestern Abend hatte ich so ein Gefühl, da habe ich nochmal nachgelegt
Durchsuchen
21.03.24 · IRW Press · WELL Health Technologies |
30.11.23 · IRW Press · WELL Health Technologies |
14.11.23 · IRW Press · CAD/USD |